Daniel R. Getts
28Patents
5h-index
15Co-inventors
62Inventor score
Filing activity: Nov 5, 2012 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10980836B1 | Therapeutic cell compositions and methods of manufacturing and use thereof | Chemistry; Metallurgy | 11 | Active |
| US9522180B2 | Peptide conjugated particles | Human Necessities | 7 | Active |
| US9616113B2 | Peptide conjugated particles | Human Necessities | 7 | Active |
| US9913883B2 | Immune-modifying nanoparticles for the treatment of inflammatory diseases | Emerging Cross-Sectional Technologies | 6 | Active |
| US8524234B2 | Antibody for selective inhibition of T-cell responses | Chemistry; Metallurgy | 5 | Active |
| US11026973B2 | Engineered phagocytic receptor compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US8722049B2 | Antibody and methods for selective inhibition of T-cell responses | Chemistry; Metallurgy | 4 | Active |
| US11013764B2 | Engineered phagocytic receptor compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10201596B2 | Peptide conjugated particles for the treatment of allergy | Human Necessities | 3 | Active |
| US11628218B2 | Engineered chimeric fusion protein compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10188711B2 | Peptide conjugated particles | Human Necessities | 2 | Active |
| US11510996B2 | Covalent polymer-antigen conjugated particles | Human Necessities | 2 | Active |
| US10617747B2 | Peptide conjugated particles | Human Necessities | 2 | Active |
| US10471093B2 | Modified immune-modulating particles | Emerging Cross-Sectional Technologies | 1 | Active |
| US11672874B2 | Methods and compositions for genomic integration | Chemistry; Metallurgy | 1 | Active |
| US11413337B2 | Peptide conjugated particles for the treatment of inflammation | Human Necessities | 1 | Active |
| US9919005B2 | Immune-modifying nanoparticles for the treatment of inflammatory diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US12319925B2 | Methods and compositions for genomic integration | Chemistry; Metallurgy | 0 | Active |
| US12252545B2 | Therapeutic cell compositions and methods of manufacturing and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11129881B2 | Peptide conjugated particles | Human Necessities | 0 | Active |
| US11944680B2 | Engineered chimeric fusion protein compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12030938B2 | Engineered chimeric fusion protein compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11020424B2 | Modified immune-modulating particles | Emerging Cross-Sectional Technologies | 0 | Active |
| US11484506B2 | Process for the preparation of tolerizing immune-modulating particles | Human Necessities | 0 | Active |
| US8968739B2 | Antibody and methods for selective inhibition of T-cell responses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.